Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 1,007,055 |
|
|||||
| News | (3) | ||||||
| Day High | 4.24 | Low High |
|||||
| Day Low | 3.52 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| G1 Therapeutics Inc | GTHX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.16 | 4.24% | 3.93 | 17:11:41 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.52 | 3.52 | 4.24 | 4.13 | 3.77 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,588 | 1,007,055 | US$ 3.93 | US$ 3,957,575 | - | 1.08 - 5.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:30:19 | 2 | US$ 3.85 | USD |
G1 Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 215.58M | 52.20M | - | 82.51M | -47.97M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
G1 Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GTHX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.19 | 4.24 | 3.52 | 3.84 | 503,115 | -0.26 | -6.21% |
| 1 Month | 4.57 | 4.895 | 3.52 | 4.37 | 656,031 | -0.64 | -14.00% |
| 3 Months | 4.74 | 5.00 | 2.01 | 3.41 | 1,179,982 | -0.81 | -17.09% |
| 6 Months | 1.35 | 5.00 | 1.2666 | 3.21 | 1,333,071 | 2.58 | 191.11% |
| 1 Year | 2.90 | 5.00 | 1.08 | 2.84 | 1,073,070 | 1.03 | 35.52% |
| 3 Years | 21.26 | 24.12 | 1.08 | 7.74 | 1,048,966 | -17.33 | -81.51% |
| 5 Years | 21.31 | 41.80 | 1.08 | 11.83 | 907,498 | -17.38 | -81.56% |
G1 Therapeutics Description
| G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer, such as cell lung cancer and breast cancer, and designs them to combine - and enhance - the anti-tumor activity of current therapies. |
